ARCHIVES

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

This article is from The Cancer Letter archive.

Vol. 29 No. 25 | June 20, 2003

Download PDF Visit The Full Archive

Related Articles

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982

Cooperative Groups Get Reprieve From Cut As Budget Is Flatlined At Fiscal 2006 Level.

June 8, 2007

In Brief: CFO Dwain Morris to Leave MD Anderson Cancer Center

May 2, 2014

Surgery Lowers Risk By 90% In Women With Gene Mutations

April 30, 2004